Parity and lactation in relation to estrogen receptor negative breast cancer in African American women
- PMID: 21846820
- PMCID: PMC3179178
- DOI: 10.1158/1055-9965.EPI-11-0465
Parity and lactation in relation to estrogen receptor negative breast cancer in African American women
Abstract
Background: Estrogen receptor (ER)-negative breast tumors and progesterone receptor (PR)-negative breast tumors occur more commonly in women of African ancestry. Recent research indicates that the effects of reproductive factors may differ by hormone receptor status. We assessed the relation of parity and lactation to incidence of ER(-)/PR(-) and ER(+)/PR(+) breast cancer in a cohort of African American women.
Methods: From 1995-2009, 457 incident cases of ER(+)/PR(+) and 318 cases of ER(-)/PR(-) breast cancer were confirmed by review of pathology data among 59,000 African American women followed in the Black Women's Health Study through biennial questionnaires. HRs and two-sided 95% CIs for the incidence of breast cancer subtypes were derived from proportional hazards regression models that controlled for age, reproductive variables, and breast cancer risk factors.
Results: Higher parity was associated with an increased risk of ER(-)/PR(-) breast cancer (HR = 1.48, 95% CI: 0.98-1.84 for 3+ versus 0 births, P(trend) = 0.009), and with a reduced risk of ER(+)/PR(+) cancer (HR = 0.53, 95% CI: 0.39-0.73 for 3+ versus 0 births, P(trend) = 0.0002). Among women who had breastfed, high parity was no longer associated with increased incidence of ER(-)/PR(-) breast, but the inverse association with ER(+)/PR(+) cancer persisted.
Conclusions: The higher incidence of ER(-)/PR(-) breast cancer in African American women may be explained in part by their higher parity and lower prevalence of breastfeeding relative to white women.
Impact: Increased breastfeeding may lead to a reduction in the incidence of this breast cancer subtype.
References
-
- Chlebowski RT, Chen Z, Anderson GL, Rohan T, Aragaki A, Lane D, et al. Ethnicity and breast cancer: factors influencing differences in incidence and outcome. J Natl Cancer Inst. 2005;97:439–448. - PubMed
-
- Bauer KR, Brown M, Cress RD, Parise CA, Caggiano V. Descriptive analysis of estrogen receptor (ER)-negative, progesterone receptor (PR)-negative, and HER2-negative invasive breast cancer, the so-called triple-negative phenotype: a population-based study from the California cancer Registry. Cancer. 2007;109:1721–1728. - PubMed
-
- Carey LA, Perou CM, Livasy CA, Dressler LG, Cowan D, Conway K, et al. Race, breast cancer subtypes, and survival in the Carolina Breast Cancer Study. Jama. 2006;295:2492–2502. - PubMed
-
- Lambe M, Hsieh C, Trichopoulos D, Ekbom A, Pavia M, Adami HO. Transient increase in the risk of breast cancer after giving birth. N Engl J Med. 1994;331:5–9. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
- R01 CA136483/CA/NCI NIH HHS/United States
- R01 CA098663/CA/NCI NIH HHS/United States
- U10 CA37429/CA/NCI NIH HHS/United States
- UL1RR031975/RR/NCRR NIH HHS/United States
- R01 CA058420/CA/NCI NIH HHS/United States
- P30 CA051008/CA/NCI NIH HHS/United States
- R01 CA133264/CA/NCI NIH HHS/United States
- R01 CA126841/CA/NCI NIH HHS/United States
- R01 CA193426/CA/NCI NIH HHS/United States
- R01 HD057966/HD/NICHD NIH HHS/United States
- P30 CA016056/CA/NCI NIH HHS/United States
- U10 CA037429/CA/NCI NIH HHS/United States
- HHSN261201000128C/CP/NCI NIH HHS/United States
- UL1 RR031975/RR/NCRR NIH HHS/United States
- P01 CA151135/CA/NCI NIH HHS/United States
- R01 CA116395/CA/NCI NIH HHS/United States
- R01 CA105274/CA/NCI NIH HHS/United States
- R21 CA149996/CA/NCI NIH HHS/United States
- R01 HD060680/HD/NICHD NIH HHS/United States
- R01 HD057210/HD/NICHD NIH HHS/United States
- U01 ES019435/ES/NIEHS NIH HHS/United States
- P30 CA51008/CA/NCI NIH HHS/United States
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials
